Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2022-06-22 00:00:00 ET · period of report 2022-06-21 · accession 0001213900-22-034366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-22 | 2022-06-21 | KTTA | STEINMAN LAWRENCE | Dir | A - Grant | $0.00 | +652.2K | 1.25M | +109% | $0 |
| D | 2022-06-22 | 2021-08-02 | KTTA | STEINMAN LAWRENCE | Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-21 | A | A | 652,174 | $0.00 | 1,252,174 | D | — | — | (F1) Represents shares of common stock of the Issuer issued in connection with the acquisition of the ALPHA-5 Integrin, LLC on June 21, 2022. |
| 2 | Derivative | Stock option (to acquire common stock) | 2021-08-02 | A | A | 100,000 | $0.00 | 100,000 | D | $6.00 · 2022-08-02 to 2031-08-02 | 600,000 Common Stock | (F2) The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to reporting person remaining employed and in good standing, one-half vesting on the first anniversary of the grant date, and the remainder vesting on the second anniversary of the grant date. |